Neurology Research International Q2
Unclaimed
Neurology Research International is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 42. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 922,5 €. The scope of the journal is focused on neurology, nervous system. It has an SJR impact factor of 0,71 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,71.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
922,5 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,71
SJR Impact factor42
H Index3
Total Docs (Last Year)36
Total Docs (3 years)166
Total Refs94
Total Cites (3 years)36
Citable Docs (3 years)2.85
Cites/Doc (2 years)55.33
Ref/DocOther journals with similar parameters
Neural Plasticity Q2
CNS Spectrums Q2
Journal of Geriatric Psychiatry and Neurology Q2
Neurology International Q2
Journal of Neuromuscular Diseases Q2
Compare this journals
Aims and Scope
Best articles by citations
Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
View moreCorrigendum to "Effect of Chronic Morphine Consumption on Synaptic Plasticity of Rat's Hippocampus: A Transmission Electron Microscopy Study"
View morePeripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data
View moreDescription of Ictal HFO Mapping in Patients with Both Temporal and Extratemporal Seizure Focus
View moreMotor Cortex Stimulation in Parkinson's Disease
View moreDoes Cerebral Hemispheric Laterality Control Swallow Performance?
View moreThe Role of Cytokines and Inflammatory Cells in Perinatal Brain Injury
View moreHuntington's Disease: An Immune Perspective
View moreShort-Term Relapse Quantitation as a Fully Surrogate Endpoint for Long-Term Sustained Progression of Disability in RRMS Patients Treated with Natalizumab
View moreThe Outcome of Agitation in Poisoned Patients in an Iranian Tertiary Care University Hospital
View moreA Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression
View moreAortic Stiffness Is Related to the Ischemic Brain Injury Biomarker N-Methyl-D-aspartate Receptor Antibody Levels in Aortic Valve Replacement
View moreAdministration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93AMouse Model of Amyotrophic Lateral Sclerosis
View moreFemale Gender Remains an Independent Risk Factor for Poor Outcome after Acute Nontraumatic Intracerebral Hemorrhage
View morePrevalence of Stroke Risk Factors and Their Distribution Based on Stroke Subtypes in Gorgan: A Retrospective Hospital-Based Study - 2015-2016
View moreKnowledge of Stroke Risk Factors and Warning Signs in Patients with Recurrent Stroke or Recurrent Transient Ischaemic Attack in Thailand
View moreEndovascular Treatment of Intracranial Artery Dissection: Clinical and Angiographic Follow-Up
View moreDeletion of Ovarian Hormones Induces a Sickness Behavior in Rats Comparable to the Effect of Lipopolysaccharide
View moreElectrophysiological Predictors of Clinical Outcome in Traumatic Neuropathies: A Multicenter Prospective Study
View moreNeuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
View morePrevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital
View moreGlial Cells in Amyotrophic Lateral Sclerosis
View morePredictor's of Mortality in Patients with Aneurysmal Subarachnoid Haemorrhage and Reebleding
View moreMechanisms of Neuroprotection by Protein Disulphide Isomerase in Amyotrophic Lateral Sclerosis
View more
Comments